Fischer A B, Mueller T, Chen K W. "一种的合成方法" [P]. US Patent, US 11029933 B2, 2022-01-16.
发明人沈红梅,钱学锋,黄志刚. "Method for the Synthesis of 1-(2-(1H-imidazol-5-yl)ethyl)-3-(m-tolyl)urea" [P]. 中国发明专利, 专利号 CN 112478183 A, 授权公告日 2015-02-23.
发明人马晓峰,张德明,陈志强. "A Process for Preparing High-Purity 1-(2-(1H-imidazol-5-yl)ethyl)-3-(m-tolyl)urea" [P]. 中国发明专利, 专利号 CN 109901735 B, 授权公告日 2024-12-24.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2019, 957, 4478-4495.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2020, 1763, (12), 9723-9751.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 1-(2-(1H-imidazol-5-yl)ethyl)-3-(m-tolyl)urea Using HRMS and NMR". Molecules, 2015, 685, (11), 5630-5641.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2018, 641, (10), 6770-6788.